More study needed or vaccine pushback? FDA lags on ruling for Novavax's COVID-19 booster

Retrieved on: 2025-04-30 16:48:00

Tags for this article:

Click the tags to see associated articles and topics

More study needed or vaccine pushback? FDA lags on ruling for Novavax's COVID-19 booster. View article details on hiswai:

Excerpt

Federal regulators need more data to evaluate the safety and efficacy of COVID-19 booster shots, said Food and Drug Administration (FDA) ...

Article found on: www.medicaleconomics.com